🇺🇸 FDA

Drug profile · INN

brinzolamide

AZARGA

approved S01EC04
US status
approved
Patents linked
3
News articles
0

Quick answer

brinzolamide (AZARGA) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN brinzolamide
Brand AZARGA
Route OPHTHALMIC
Formulation SUSPENSION/DROPS
ATC code S01EC04

Related patents

Search patents →

  1. US 11826429

    Pharmaceutical composition comprising brinzolamide

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10632198

    Pharmaceutical composition comprising brinzolamide

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9820991

    Pharmaceutical composition comprising brinzolamide

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is brinzolamide?

brinzolamide (AZARGA) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for brinzolamide?

AZARGA is a marketed brand name for brinzolamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of brinzolamide?

brinzolamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.